|
| [April 05, 2012] |
 |
Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors
DENVER --(Business Wire)--
The Colorado BioScience Association (CBSA) appointed four new board
members at its 2012 Annual All-Member Meeting held at the Westin
Westminster, Westminster, CO, yesterday. The announcement is made
jointly by Steve Orndorff, Ph.D., Chairperson of the Board of Directors
and Holli Riebel, CBSA President & CEO of CBSA.
Newly appointed CBSA board members include:
-
James Chomas, Ph.D., Founder & CEO, Surefire Medical -
Westminster - surefiremedical.com
-
Scott Deeter, President & CEO, Ventria Bioscience - Fort
Collins - www.ventria.com
-
Brent Fassett, Partner, Cooley LLP - Broomfield - www.cooley.com
-
Kerry Ingalls, Vice President of Colorado Operations,
Amgen - Boulder/Longmont - www.amgen.com
Riebel says: "CBSA's board is a prestigious group of industry leaders
comprised of representatives of biotechnology, medical device,
diagnostic, pharmaceutical, health care providers, research institutions
and those businesses that provide critical services and products to
bioscience companies. Board members commit to a three-year term to
support CBSA's mission to support the regional bioscience community
through advocacy, resources and advancement of opportunities for
collaboration. CBSA board members work in partnership with staff to
support the drive and determination of over 600 Colorado bioscience
companies that work to improve lives locally and around the world."
"On behalf of the Board of Directors, I would like to thank the retiring
eleven directors for their service and welcome the four new appointees,"
Orndorff stated. Special recognition was given to Norwood Robb for
serving on the board for ten years. The Executive Officers , in addition
to Orndorff, is now instated as Derek Cole, Board Vice Chair, Vice
President, Investor Relations & Corporate Communications, ARCA
Biopharma; Jim Wilson, Board Treasurer, Senior Audit Manager, Ernst &
Young; and John Dunning, Board Secretary, President & CEO, Clarimedix
Inc.
Reappointments of CBSA board members include:
-
Lisa Drake, Director Government Affairs, Monsanto - www.monsanto.com
-
Dick Hinson, Senior Vice President, Aurora Economic Development
Council - www.auroraedc.com
-
Rick Jory, President and CEO, Sandhill Scientific, Inc - www.sandhillsci.com
(Past Board Chair)
-
Mark Lupa, Partner, High Country Venture - highcountryventure.com
-
Steve Orndorff, President and CEO, Ariel Pharmaceuticals - arielpharma.com
(Board Chair)
-
Mark Spiecker, Chief Executive Officer, Sharklet Technologies - www.sharklet.com
(Education Committee Chair)
-
Dan Wittenberg, Partner, Snell & Wilmer LLP - www.swlaw.com
(Public Policy Committee Chair)
Link to the CBSA 2012 Board Member profiles: http://www.cobioscience.com/about-us/board-of-directors
The CBSA's 2012 association sponsors include:
About Colorado BioScience Association
The CBSA is a not-for-profit organization providing services and support
for Colorado's bioscience industry. With more than 350 members, CBSA
actively works to promote the growth of the industry by advocating for a
better business environment, growing the state's biotech workforce,
fighting for policies that support a strong bioscience industry in the
state, and speaking with a single voice on behalf of the industry. For
more information, visit www.cobioscience.com.
CBSA also is found on these social media sites:
Twitter (News - Alert): twitter.com/COBioscience LinkedIn (News - Alert)
Group: www.linkedin.com/groups?about=&gid=98468&trk=anet_ug_grppro Facebook (News - Alert)
Fan Page: www.facebook.com/ColoradoBioScienceAssociation News
Feed: coloradobio.blogspot.com YouTube (News - Alert)
Channel: www.youtube.com/COBioscience Pinterest:
pinterest.com/COBioscience

[ Back To SIP Phones Homepage's Homepage ]
|